SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

HC Wainwright & Co. Maintains Buy on Aquestive Therapeutics, Raises Price Target to $15

HC Wainwright & Co. maintains Aquestive Therapeutics (NASDAQ:AQST) with a Buy and raises the price target from $13 to $15.

Benzinga · 05/22/2020 11:01

HC Wainwright & Co. maintains Aquestive Therapeutics (NASDAQ:AQST) with a Buy and raises the price target from $13 to $15.